Skip Navigation

Lupus Research Alliance

priority review

LRA Statement: Potential Lupus Nephritis Drug Voclosporin Granted Priority Review by the U.S. FDA

NEW YORK, NY. July 22, 2020. The Lupus Research Alliance congratulates Aurinia Pharmaceuticals Inc. on acceptance of its NDA...

Aurinia Completes NDA and Requests Priority Review of Voclosoporin by FDA for Lupus Nephritis

Lupus Research News

May 28, 2020 The Lupus Research Alliance is pleased to share that Aurinia Pharmaceuticals Inc submitted a New Drug Application...